CAMPHealthcareMicro-Cap
Camp4 Therapeutics Corp Insider Trading Activity
Every SEC Form 4 insider transaction reported for Camp4 Therapeutics Corp (CAMP), sourced directly from SEC EDGAR and updated as new filings are accepted.
By Trabud Research Team · SEC Form 4 & insider trading data analysts
Last updated:
Quick Answer
Are CAMP insiders buying or selling?
Camp4 Therapeutics Corp insiders reported 15 open-market buys ($90.0M) and 0 sells ($0) across 15 Form 4 filings — a net buying position of $90.0M.
Source: SEC EDGAR Form 4
Key Statistics (as of Sep 16, 2025)
Total Form 4 filings
15
SEC EDGAR
Insider filers
11
Insider buys (15)
$90.0M
Insider sells (0)
$0
Insider sentiment
Net buyingNet insider flow of $90.0M in net buying.
Recent CAMP insider transactions
| Date | Insider | Role | Type | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Sep 16, 2025 | Kush Parmar | 10% Owner | Purchase | 2.9M | $1.53 | $4.5M |
| Sep 11, 2025 | Amy W Schulman | 10% Owner | Purchase | 1.3M | $1.53 | $2.0M |
| Sep 11, 2025 | Amir Nashat | Director, 10% Owner | Purchase | 1.3M | $1.53 | $2.0M |
| Sep 11, 2025 | Yuri Maricich | Chief Medical Officer | Purchase | 6.1K | $1.65 | $10.0K |
| Sep 11, 2025 | Kelly Gold | Chief Financial Officer | Purchase | 6.1K | $1.65 | $10.0K |
| Sep 11, 2025 | Josh Mandel-Brehm | Chief Executive Officer | Purchase | 6.1K | $1.65 | $10.0K |
| Sep 11, 2025 | Richard A Young | Director | Purchase | 15.2K | $1.65 | $25.0K |
| Oct 22, 2024 | Amy W Schulman | 10% Owner | Purchase | 909.1K | $11.00 | $10.0M |
| Oct 17, 2024 | Michael P. Rubin | 10% Owner | Purchase | 763.6K | $11.00 | $8.4M |
| Oct 17, 2024 | Marc L Andreessen | 10% Owner | Purchase | 727.3K | $11.00 | $8.0M |
| Oct 17, 2024 | Enavate Sciences GP, LLC | 10% Owner | Purchase | 1.4M | $11.00 | $15.0M |
| Oct 15, 2024 | Amy W Schulman | 10% Owner | Purchase | 909.1K | $11.00 | $10.0M |
| Oct 15, 2024 | Kush Parmar | 10% Owner | Purchase | 909.1K | $11.00 | $10.0M |
| Oct 15, 2024 | Amir Nashat | Director, 10% Owner | Purchase | 909.1K | $11.00 | $10.0M |
| Oct 15, 2024 | Andrew J. Schwab | Director, 10% Owner | Purchase | 909.1K | $11.00 | $10.0M |
Showing the 15 most recent of 15 Form 4 filings for Camp4 Therapeutics Corp.
Most active CAMP insiders
- Amy W Schulman3 filings
- Kush Parmar2 filings
- Amir Nashat2 filings
- Marc L Andreessen1 filing
- Andrew J. Schwab1 filing
Ask anything about CAMP insider activity
Use Trabud's AI agent to query Camp4 Therapeutics Corp's Form 4 history in plain English — "Show me CAMP CEO purchases this year" or compare it against any other ticker.
Open the AI agentCAMP insider trading FAQ
Are Camp4 Therapeutics Corp insiders buying or selling?
Across 15 SEC Form 4 filings, Camp4 Therapeutics Corp (CAMP) insiders reported 15 open-market purchases totaling $90.0M and 0 sales totaling $0. That is a net buying position of $90.0M.
How many insiders trade CAMP stock?
11 distinct insider filers — officers, directors, 10%+ owners, and investment groups filing jointly — have reported Form 4 transactions for Camp4 Therapeutics Corp. The most recent filing was accepted on Sep 16, 2025.
Where does Trabud get CAMP insider trading data?
All CAMP insider trading data comes directly from official SEC EDGAR Form 4 filings, which corporate insiders must submit within two business days of a transaction under Section 16(a) of the Securities Exchange Act of 1934.
Looking for another company? Browse all tracked companies.